Navigation Links
Stem Cell Markets - 2013 Report Examines the Use of Stem Cells in Developing New Therapies for Disease
Date:11/20/2013

DUBLIN, Ireland, November 20, 2013 /PRNewswire/ --

Research and Markets
( http://www.researchandmarkets.com/research/59bkth/stem_cell_markets) has announced the addition of the "Stem Cell Markets" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells.

Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ injuries, including cardiovascular disease, neurological disease, musculoskeletal disease, diabetes and hematopoietic disorders. Stem cell fate is determined by both intrinsic regulators and the extra-cellular environment (niche), and their expansion and differentiation ex vivo are generally controlled by growing them in a specific configuration (monolayer or three-dimensional culture). This process, which is vital to enable stem cells to be used for therapeutic purposes, is called differentiation. Differentiation is a process involving unspecialized cells progressing to become specialized cells with restricted developmental potential.

The purpose of this report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods that are currently i
'/>"/>

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
2. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
6. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
7. Animal Biotechnology - Technologies, Markets and Companies
8. Gene Therapy - Technologies, Markets and Companies
9. Biomarkers - Technologies, Markets and Companies
10. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
11. MarketsandMarkets: Chronic Lymphocytic Leukemia Therapeutics Market Worth $2.2 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Ill. , Dec. 19, 2014 Naurex ... develop novel drugs for diseases of the central nervous ... president and chief executive officer, will present at the ... Riedel,s presentation will take place at 3:00 p.m. PST ... Francis in San Francisco, Calif. ...
(Date:12/19/2014)... 2014 BioPlus Specialty Pharmacy ... pharmacies, has an expanded team of Regional Pharmaceutical ... for prescriber offices in their regions, with specific ... have a variety of Regional Pharmaceutical Care Liaisons ... in hepatitis C help prescribers understand all the ...
(Date:12/19/2014)... iLab Solutions, the global leader in core ... as the new Director of Institutional Implementations and Sarah ... two new leadership positions were created to support iLab’s ... iLab continues to meet the needs of its growing ... has been deployed at over 450 core facilities across ...
(Date:12/19/2014)... 18, 2014 Egenix, Inc. is pleased to announce ... of the Board, to succeed Donald Fresne ; Mr. ... continue as a member of the Board.  In recognition of ... the company over almost twenty years, the Board designated Mr. ... Directors has established a Search Committee to find a suitable ...
Breaking Biology Technology:Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2
... 19 Alexandria Real Estate Equities, Inc. (NYSE: ... offering of 7,000,000 shares of common stock at a price ... of 4,500,000 shares. Merrill Lynch & Co., Citi and ... & Woods and Scotia Capital acted as co-managers in connection ...
... - EPA Exercises Option to Extend Contract with Caliper ... (Nasdaq: CALP ), a leading provider of ... research, today announced that the United States Environmental Protection ... generated by Caliper Discovery Alliances and Services (CDAS) under ...
... Administration, Bioavailability, Safety, and Efficacy of TreatmentsMOUNTAIN ... its recent analysis of the ocular drug ... Pharma with the 2009 North American Frost ... Advancement of the Year, for its two ...
Cached Biology Technology:Alexandria Real Estate Equities, Inc. Announces Pricing of Public Follow-On Offering of 7,000,000 Shares of Common Stock 2Alexandria Real Estate Equities, Inc. Announces Pricing of Public Follow-On Offering of 7,000,000 Shares of Common Stock 3EPA Presents Initial Results from Caliper Life Sciences' ToxCast Screening Effort 2EPA Presents Initial Results from Caliper Life Sciences' ToxCast Screening Effort 3EPA Presents Initial Results from Caliper Life Sciences' ToxCast Screening Effort 4Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies 2Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies 3Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies 4
(Date:12/19/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has ... North America Perimeter Security Systems Market" report to ... The North American perimeter security market is ... 2014 to 2019. Although the U.S. market holds a ... is expected to grow at a higher CAGR ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Clinical Practices (GCP) audit to confirm its adherence ... regulations. This accomplishment enables HITLAB to conduct regulated ... the highest principles for patient safety and research ... global healthcare access, quality, and delivery with innovative ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced ... the APAC Region 2015-2019"  report to their offering. ... this market is advances in technology. With continuous ... biometric solutions to the latest standard that meets ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... has published the genome sequence of the rhesus macaque ... genomes. Published April 13 in a special section of ... primate species share about 93 percent of their DNA, ... In its paper, the Rhesus Macaque Genome Sequence and ...
... at the University of Chicago have found an unsuspected link ... and triglycerides in the blood) in mice. The finding could ... disease by lowering elevated lipid levels. , In ... by James C. Lo, an MD, PhD student, in the ...
... asbestos exposure ?have a higher survival rate when treated with ... finds. , Mesothelioma, a rare but aggressive form of cancer ... abdomen, is associated with exposure to asbestos. There is no ... and cisplatin ?along with the vitamin supplements folic acid and ...
Cached Biology News:Analysis of rhesus monkey genome uncovers genetic differences with humans, chimps 2Analysis of rhesus monkey genome uncovers genetic differences with humans, chimps 3Link found between immune system and high plasma lipid levels 2Chemo combination improves survival in asbestos-related cancer 2Chemo combination improves survival in asbestos-related cancer 3
Peptide-affinity Purified Polyclonal Antibody to Histamine H2 Receptor...
Mouse Wnt-9b Biotinylated Affinity Purified PAb ENTREZ GeneID: 22412...
...
... Ambions MAXIscript In Vitro Transcription Kits synthesize ... x 10 9 cpm/g. High specific ... ribonuclease protection assays, in situ hybridization, and ... used for the synthesis of modest amounts ...
Biology Products: